Heron Therapeutics | HRTX - EPS Earnings Per Share

Stock Price
0.96
Daily Change
0.02 2.13%
Monthly
6.67%
Yearly
-47.99%
Q2 Forecast
0.83

Heron Therapeutics reported $-0.02 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
ALKERMES USD 0.29 0.2 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.14 0.06 Dec/2025
ANI Pharmaceuticals USD 2.33 0.29 Dec/2025
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.06 0.64 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Surmodics USD 0 0.25 Jun/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Veracyte USD 0.53 0.02 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025